






Study with the several resources on Docsity
Earn points by helping other students or get them with a premium plan
Prepare for your exams
Study with the several resources on Docsity
Earn points to download
Earn points by helping other students or get them with a premium plan
Community
Ask the community for help and clear up your study doubts
Discover the best universities in your country according to Docsity users
Free resources
Download our free guides on studying techniques, anxiety management strategies, and thesis advice from Docsity tutors
Material Type: Exam; Class: MEDICINAL CHEMISTRY & DRUG DES; Subject: Medicinal Chemistry; University: Virginia Commonwealth University; Term: Spring 2005;
Typology: Exams
Limited-time offer
Uploaded on 11/25/2020
5
(2)10 documents
1 / 10
This page cannot be seen from the preview
Don't miss anything!
On special offer
Name:____________________________ Pledge: _______________________
(All questions are 2.5 points unless otherwise stated.)
W.H. Soine
A) -3 D) 9 B) 1 E) 13 C) 5
A) Mouth (pH 6-7) B) Stomach (pH 1-3) C) Small Intestine (pH 7-7.5) D) Colon (pH 8) E) It is not absorbed when given orally
Which compound is more lipophilic?
A) t-butylbenzene B) n-butylbenzene C) They are both equally lipophilic
CH (^3)
CH (^3)
CH (^3) CH (^3) i (^) ii
O NH
F 3 C
CH (^3)
A) -CF 3 (1.07) B) -Br (0.94) C) -OCH 3 (-0.02) D) -CH 2 OH (-1.03) E) They will all make the drug equally lipophilic
Identify the strongest and most important type of bonding force involved in this interaction.
A) reinforced ionic D) dipole-dipole B) ionic E) hydrophobic C) hydrogen
A) Geometric Isomers B) Optical Isomers C) Configurational Isomers D) Conformational Isomers E) The same compounds
Methamphetamine ASP301 on CYP2D
Ph
H H
NHCH (^3) NHCH (^3)
H Ph
H
A) A material with unknown or unanticipated pharmacological effects. B) A new compound that will soon replace heroin on the “street”. C) A highly toxic drug. D) An extremely pure form of heroin. E) All of the above.
R.A. Glennon
A) from axon to dendrite C) from terminal to axon B) from dendrite to axon D) from axon to synapse
A) electrical C) mechanical B) chemical D) nonexistent
A) release B) interaction with postsynaptic receptors C) biosynthesis D) reuptake
A) somaotodendritic receptors C) serotonin receptors B) postsynaptic receptors D) transporters (e.g. SERT)
A) seven transmembrane-spanning helicies B) activation of a second messenger system C) control of a ligand-gated ion channel D) neurotransmission
A) TRUE B) FALSE
A) thioxanthenes C) benzodiazepines B) butyrophenones D) phenothiazines
A) act, at least in part, by blocking dopamine D2 receptors B) prevent symptoms of extrapyramidal stimulation C) are serotonin receptor agonists D) are useful for treating symptoms associated with anxiety
A) do not bind at dopamine receptors B) do not bind at serotonin (5-HT) receptors C) bind both at dopamine and serotonin receptors D) produce exaggerated extrapyramidal stimulation (EPS)
A) it behaves as a releaser of dopamine B) it behaves as a releaser of serotonin C) it blocks the reuptake of dopamine D) it blocks the reuptake of serotonin
A) it behaves as a releaser of dopamine B) it behaves as a releaser of serotonin C) it blocks the reuptake of dopamine D) it blocks the reuptake of serotonin
A) MDMA B) Methylenedioxymethamphetamine C) Cathinone D) DOM E) A) and B)
A) Ecstasy D) X B) Khat E) None of these C) Love Drug
A) Stereoselectivity D) A) and C) B) Stereospecificity E) All of these C) Mechanism of Action
A) S(+)-MDA is a hallucinogen B) R(-)-MDA is a stimulant C) R(-)-MDA is a hallucinogen D) A) and B) E) A) and C)
A) The drug discrimination procedure can provide qualitative and quantitative information about a compound. B) Only stimulants and hallucinogens have been used in drug discrimination studies. C) Results from some drug discrimination studies have been shown to parallel(correlate) with human studies. D) All of the above E) B) and C)
L.B. Kier
A) a synthetic method B) dependent upon crystal studies C) a modeling method D) an experimental method
A) the liver B) the region of drug-receptor encounter C) the outcome of QSAR D) the region of excretion
A) a feature on the drug molecule B) the entire drug molecule C) the measure biological response D) part of a macromolecule in the body
A) part of the drug moleecule B) the entire drug molecule C) the measure of drug activity D) a measure of biological response
A) a model of the receptor B) a model of the pharmacophore C) a model of the structure D) a model relating activity with structure
A) The patients should be given the same dose as for normal individuals. B) The patient should be given a higher dose than that given to normal individuals C) The patient should be given a lower dose than that given to normal individuals. D) The plasma concentration of the free (unbound drug) will be significantly lower compared to normal individuals. E) None of the above.
A) The metabolism of drugs always increases biological availability of the parent compound. B) Phase II enzymes are usually conjugative enzymes. C) Oxidative metabolism is the major Phase I pathway that is responsible for removing substituents from functional groups. D) The liver is the major organ involved in drug metabolism. E) Some metabolism of drugs also occurs in the gut wall.
A) The acetaminophen (Tylenol ®) is converted to a reactive oxidative metabolite. B) This reactive metabolite is rapidly detoxified by glutathione conjugation. C) The glutathione conjugates are readily excreted in the urine as harmless metabolites. D) At high doses the glutathione is depleted thereby enabling the reactive metabolites to attack nulceophilic macromolecules. E) Enzymes responsible for formation of reactive metabolites are induced.